Coronary revascularization (ANGIO or CABG)

I9_REVASC

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

21786

diagram downward connector
I9_REVASC

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 21786 5248 16538
Unadjusted prevalence (%) 6.12 2.65 10.51
Mean age at first event (years) 64.59 66.13 64.10

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.10 [1.86, 2.38] 1.5e-31 5970
15 years 0.01 1.52 [1.37, 1.69] 2.8e-15 3178
5 years 0.00 1.99 [1.81, 2.19] 3.2e-45 1295
1 year 0.00 5.06 [4.46, 5.74] <1e-100 597

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: I9_REVASC – Coronary revascularization (ANGIO or CABG)
GWS hits: 90

Survival analyses between endpoints

Plot

before Coronary revascularization (ANGIO or CABG)
after Coronary revascularization (ANGIO or CABG)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Coronary revascularization (ANGIO or CABG)